258 related articles for article (PubMed ID: 16503077)
21. [Evaluation of the hepatocellular carcinoma staging systems].
Um SH
Korean J Hepatol; 2006 Jun; 12(2):251-6. PubMed ID: 16804352
[No Abstract] [Full Text] [Related]
22. Critical evaluation of the different staging systems for hepatocellular carcinoma.
Wildi S; Pestalozzi BC; McCormack L; Clavien PA
Br J Surg; 2004 Apr; 91(4):400-8. PubMed ID: 15048738
[TBL] [Abstract][Full Text] [Related]
23. [Why no consensus prognostic classification for hepatocellular carcinoma?].
Barbare JC; Bellenguez A; Diouf M
Rev Prat; 2013 Feb; 63(2):218-9. PubMed ID: 23513789
[No Abstract] [Full Text] [Related]
24. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems.
Cammà C; Di Marco V; Cabibbo G; Latteri F; Sandonato L; Parisi P; Enea M; Attanasio M; Galia M; Alessi N; Licata A; Latteri MA; Craxì A
Aliment Pharmacol Ther; 2008 Jul; 28(1):62-75. PubMed ID: 18373636
[TBL] [Abstract][Full Text] [Related]
25. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract][Full Text] [Related]
26. Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score.
Kitai S; Kudo M; Minami Y; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Oncology; 2008; 75 Suppl 1():83-90. PubMed ID: 19092276
[TBL] [Abstract][Full Text] [Related]
27. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patients.
Chen CH; Hu FC; Huang GT; Lee PH; Tsang YM; Cheng AL; Chen DS; Wang JD; Sheu JC
Eur J Cancer; 2009 Jun; 45(9):1630-9. PubMed ID: 19157858
[TBL] [Abstract][Full Text] [Related]
28. Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making.
Addissie BD; Roberts LR
Clin Liver Dis; 2015 May; 19(2):277-94. PubMed ID: 25921663
[TBL] [Abstract][Full Text] [Related]
29. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
Olthoff KM; Forner A; Hübscher S; Fung J
Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
[No Abstract] [Full Text] [Related]
30. Prognostic Factors and Staging Systems in Hepatocellular Carcinoma.
Selçuk H
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):45-49. PubMed ID: 28301998
[TBL] [Abstract][Full Text] [Related]
31. Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Earl TM; Chapman WC
Ann Surg Oncol; 2011 May; 18(5):1217-8. PubMed ID: 21327456
[No Abstract] [Full Text] [Related]
32. Advancements in hepatocellular carcinoma.
Kulik LM
Curr Opin Gastroenterol; 2007 May; 23(3):268-74. PubMed ID: 17414842
[TBL] [Abstract][Full Text] [Related]
33. Comparison of staging systems to predict survival in hepatocellular carcinoma.
Pascual S; Zapater P; Such J; García-Herola A; Sempere L; Irurzun J; Palazón JM; Carnicer F; Pérez-Mateo M
Liver Int; 2006 Aug; 26(6):673-9. PubMed ID: 16842323
[TBL] [Abstract][Full Text] [Related]
34. Current status of treatment of hepatocellular carcinoma.
Tang ZY
Chin Med J (Engl); 1985 Apr; 98(4):257-64. PubMed ID: 2408825
[No Abstract] [Full Text] [Related]
35. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy.
Seong J; Shim SJ; Lee IJ; Han KH; Chon CY; Ahn SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1037-42. PubMed ID: 17234356
[TBL] [Abstract][Full Text] [Related]
36. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.
Huo TI; Huang YH; Lin HC; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
Am J Gastroenterol; 2006 May; 101(5):975-82. PubMed ID: 16573785
[TBL] [Abstract][Full Text] [Related]
37. Staging for hepatocellular carcinoma: treatment strategy matters.
Huo TI; Huang YH
Hepatology; 2005 Mar; 41(3):678; author reply 678-9. PubMed ID: 15723331
[No Abstract] [Full Text] [Related]
38. Staging for liver cancer.
Daniele B; Perrone F
Clin Liver Dis; 2005 May; 9(2):213-23, vi. PubMed ID: 15831269
[TBL] [Abstract][Full Text] [Related]
39. Many staging systems for hepatocellular carcinoma: evolution from Child-Pugh, Okuda to SLiDe.
Dohmen K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1227-32. PubMed ID: 15482527
[No Abstract] [Full Text] [Related]
40. Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408).
Vauthey JN; Pawlik TM; Lauwers GY; Nagorney DM; Roh MS; Curley SA; Poon RT; Belghiti J; Greene F; Michael Henderson J
Br J Surg; 2004 Aug; 91(8):1072. PubMed ID: 15286973
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
